Publicaciones en colaboración con investigadores/as de University of Bern (4)

2023

  1. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 4, pp. 1060-1072

2020

  1. State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 4, pp. 746-760

2018

  1. Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases

    Allergo Journal International, Vol. 27, Núm. 8, pp. 245-255

2015

  1. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, Núm. 7, pp. 727-754